These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34669176)

  • 21. Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpura.
    Zhang Y; Kolesar JM
    Clin Ther; 2011 Nov; 33(11):1560-76. PubMed ID: 22054810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia: a retrospective study.
    Eser A; Toptas T; Kara O; Sezgin A; Noyan-Atalay F; Yilmaz G; Ozgumus T; Pepedil-Tanrikulu F; Kaygusuz-Atagunduz I; Firatli-Tuglular T
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):47-52. PubMed ID: 26258668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Maintenance of efficacy and its predictors after discontinuation of eltrombopag in adults with primary immune thrombocytopenia].
    Sun HP; You JH; Chen QS; Wang J; Li JM
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):32-37. PubMed ID: 36987720
    [No Abstract]   [Full Text] [Related]  

  • 24. [Eltrombopag for the treatment of primary immune thrombocytopenia in 23 pediatric patients].
    Huang YT; Liu XF; Chen YF; Fu RF; Liu W; Xue F; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1031-1034. PubMed ID: 32023736
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.
    Wong RSM; Saleh MN; Khelif A; Salama A; Portella MSO; Burgess P; Bussel JB
    Blood; 2017 Dec; 130(23):2527-2536. PubMed ID: 29042367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice.
    Cheng X; Fu L; Ma J; Gu H; Chen Z; Zhao L; Wang X; Wu R
    Blood Adv; 2021 Oct; 5(19):3799-3806. PubMed ID: 34605871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
    Aoki T; Harada Y; Matsubara E; Suzuki T; Oyama T; Kasai M; Uchida T; Ogura M
    J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
    Tripathi AK; Shukla A; Mishra S; Yadav YS; Yadav DK
    Int J Hematol; 2014 Apr; 99(4):413-7. PubMed ID: 24526570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching between eltrombopag and recombinant human thrombopoietin in patients with immune thrombocytopenia: an observational study.
    Cai X; Fu H; Zhao X; Lu J; Jiang Q; Chang Y; Huang X; Zhang X
    Chin Med J (Engl); 2022 Oct; 135(19):2344-2350. PubMed ID: 36535011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura.
    Uğur MC; Namdaroğlu S; Doğan EE; Turan Erkek E; Nizam N; Eren R; Bilgir O
    Turk J Haematol; 2021 Aug; 38(3):181-187. PubMed ID: 34162173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of myelofibrosis during eltrombopag treatment in a patient with immune thrombocytopenia].
    Horikoshi A; Tsukuda J; Abe R; Fujiwara N; Ito E; Takaku T
    Rinsho Ketsueki; 2016 May; 57(5):638-41. PubMed ID: 27263792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis.
    Patwardhan P; Landsteiner A; Lal LS; Geevarghese L; Le L; Nandal S; Cuker A
    Ann Hematol; 2022 Jan; 101(1):11-19. PubMed ID: 34505942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome: From Megakaryopoiesis to Immunomodulation.
    Fattizzo B; Levati G; Cassin R; Barcellini W
    Drugs; 2019 Aug; 79(12):1305-1319. PubMed ID: 31292909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eltrombopag-induced liver dysfunction during the treatment of immune thrombocytopenia and its risk factors.
    Zhang P; Miao W
    Ann Palliat Med; 2021 Jun; 10(6):6419-6424. PubMed ID: 34237963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a role for low-dose eltrombopag as maintenance therapy in the treatment of immune thrombocytopenia?
    Vlachaki E; Sousos N; Perifanis V; Kaiafa G; Onoufriadis I; Hatzitolios A; Boura P
    Acta Haematol; 2015; 133(1):78-82. PubMed ID: 25170628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag.
    Hernández-Sánchez JM; Bastida JM; Alonso-López D; Benito R; González-Porras JR; De Las Rivas J; Hernández Rivas JM; Rodríguez-Vicente AE
    Platelets; 2020 Nov; 31(8):993-1000. PubMed ID: 31838946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eltrombopag for use in children with immune thrombocytopenia.
    Kim TO; Despotovic J; Lambert MP
    Blood Adv; 2018 Feb; 2(4):454-461. PubMed ID: 29487060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cost-effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States.
    Tremblay G; Dolph M; Roy AN; Said Q; Forsythe A
    Clin Ther; 2020 May; 42(5):860-872.e8. PubMed ID: 32199608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of lymphocyte phenotypes and outcomes after discontinuing eltrombopag in immune thrombocytopenia.
    Oka S; Ono K; Nohgawa M
    Int J Clin Pract; 2021 May; 75(5):e14057. PubMed ID: 33529437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eltrombopag for treatment of thrombocytopenia-associated disorders.
    Merli P; Strocchio L; Vinti L; Palumbo G; Locatelli F
    Expert Opin Pharmacother; 2015; 16(14):2243-56. PubMed ID: 26364898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.